KRYSTAL MITCHELL: Open Payments
NPI 1356956890 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,135 in 196 payments from 13 companies in 2025. Trend: 2023 $1,890 · 2024 $2,466 · 2025 $5,135
Food & beverage: $3,855Consulting: $1,280
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $1,572 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $701 |
| Otsuka America Pharmaceutical, Inc. | 36 | $642 |
| Janssen Pharmaceuticals, Inc | 26 | $594 |
| Neurocrine BioSciences, Inc. | 37 | $578 |
| Vanda Pharmaceuticals Inc. | 16 | $351 |
| Teva Pharmaceuticals USA, Inc. | 17 | $279 |
| Alkermes, Inc. | 13 | $165 |
| Axsome Therapeutics, Inc. | 5 | $93 |
| ABBVIE INC. | 4 | $80 |
Products named: CAPLYTA, INGREZZA, REXULTI, INVEGA SUSTENNA, COBENFY, FANAPT, AUSTEDO XR, ARISTADA.
Industry payments across KS — which companies pay providers there.
